Last reviewed · How we verify
Epinephrin 0.03
Epinephrin 0.03 is a Small molecule drug developed by Kasr El Aini Hospital. It is currently FDA-approved.
At a glance
| Generic name | Epinephrin 0.03 |
|---|---|
| Sponsor | Kasr El Aini Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance (PHASE4)
- Effect of Adding a Low-Dose Epinephrine Bolus Prior to Infusion on Maternal Hemodynamic Stability During Cesarean Section (PHASE3)
- Vasoactive Drugs in Intensive Care Unit (PHASE4)
- Dose Response of Epinephrine (EARLY_PHASE1)
- Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects (PHASE1)
- Multimodal Vasopressor Strategy in Septic Shock (PHASE2, PHASE3)
- A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone (PHASE2)
- Epinephrine Vs Norepinephrine Infusion During Caesarean Delivery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epinephrin 0.03 CI brief — competitive landscape report
- Epinephrin 0.03 updates RSS · CI watch RSS
- Kasr El Aini Hospital portfolio CI
Frequently asked questions about Epinephrin 0.03
What is Epinephrin 0.03?
Epinephrin 0.03 is a Small molecule drug developed by Kasr El Aini Hospital.
Who makes Epinephrin 0.03?
Epinephrin 0.03 is developed and marketed by Kasr El Aini Hospital (see full Kasr El Aini Hospital pipeline at /company/kasr-el-aini-hospital).
What development phase is Epinephrin 0.03 in?
Epinephrin 0.03 is FDA-approved (marketed).
Related
- Manufacturer: Kasr El Aini Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing